Detection of HER-2/Neu status by immunohistochemistry and fluorescence in situ hybridization in breast

Abstrakt

HER-2/neu protein is overexpressed in 15-20% of invasive breast carcinomas and has been reported to be an independeatly adverse prognostic and predictive factor in patients with breast cancer.